Conferences and Events





The biggest ICT event in the EU calendar, ICT 2015 – Innovate, Connect, Transform- was held in Lisbon, Portugal, on October 20th – 22nd, 2015. The ICT 15 event, organised by the European Commission,  presented interesting debates, the latest news on the European Commission’s new policies and initiatives with regard to R&I in ICT, and it also represented a great networking opportunity to start partnerships with international experts and actors in the ICT domain. CARDIOPROOF attended to this important event by organising, in collaboration with its cognate project MD-PAEDIGREE, winner of the last event ICT 13 held in Vilnius, and with the GÉANT network, a booth in which novel applications to support clinical diagnostic and decision making directly at the point of care has been showcased. Furthermore, CARDIOPROOF  took part to the networking session “Enhanced Consent: a vision for Patient Data Protection and Data Management” (Wednesday 21st, 9-9:45, Room 13), during which the new privacy and regulatory issues related to the process of data-intensive scientific discovery and the associated new emerging scenarios have been presented and discussed.


E-health Week 2015


A preliminary dissemination activity has taken place within the eHealth Week, held in Riga, on May 11th -13th 2015. Cardioproof was, in fact, invited to present within the Speakers’ Corner organised by the EC within the event.



17th European Health Forum Gastein (1 – 3 October 2014)

Over the past decade the European Health Forum Gastein has developed into an indispensable institution in the scope of European health policy. It has made a decisive contribution to the development of guidelines and above all the cross-border exchange of experience, information and cooperation.

The overall aim is a platform for discussion for the various stakeholders in the field of public health and health care.

About 600 leading experts participate in the annual conference held in the Gastein Valley in Austria in October. The unparalleled mix of participants including leading country- and EU-level representatives from the areas of health policy, administration, science, business and patient organisations, are especially critical to the success of this event.



Virtual Physiological Human Conference 2014

Trondheim September 9-12, 2014

This biannual conference series grew out of the successful FP7 Virtual Physiological Human Network of Excellence. It has become one of the major instruments for maintaining the coherence and momentum of the highly multidisciplinary VPH community.

The VPH mission is driven by the conviction that if we are to succeed in developing a real predictive, preventive and participatory medicine envisioned by so many, there is no substitute for building much stronger transdisciplinary ties between the life sciences, the mathematical sciences and engineering throughout the whole spectrum of basic, translational and applied research.

On January 14 this year the European Parliament urged the Commission and the Member States to continue to support innovative solutions for person-centred care, and the VPH initiative was specifically endorsed in this connection. This may open for several exciting opportunities for the VPH community in the years to come. VPH2014 is thus arguably one of the most important European conferences to attend this year if you want to take advantage of the opportunity window the EU Parliament has opened for us.

The Publishing Editor of Interface Focus, Tim Holt, has invited the submission of a proposal for an Interface Focus Theme Issue titled “The Quantitative Human Physiome – a necessary key to the creative destruction of medicine“. The Theme Issue will be developed from a selected set of VPH2014 oral and poster presentations.  If you have a particular interest in contributing to this Theme Issue and want to see the preliminary proposal leading to this invitation from Tim Holt, please send an email to

Please note that on September 9 there will be a satellite symposium in conjunction with the conference that addresses to which degree computational physiology in the broad sense may become an unprecedented guide for identifying which new phenotypic data (and thus which new phenotyping technologies) should be selected in the context of biobanks and large population-based studies, and how such data may become transformative for the development of a Quantitative Human Physiome.